Good to know_老虎社区_美港股上老虎

2021-08-25

Good to know

After-Hours Stock Movers : Limoneira,Urban Outfitters,Mimecast and more

免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":837908614,"tweetId":"837908614","gmtCreate":1629850861038,"gmtModify":1633682008521,"author":{"id":3577664011514694,"idStr":"3577664011514694","authorId":3577664011514694,"authorIdStr":"3577664011514694","name":"Nez","avatar":"https://static.tigerbbs.com/b32d6842fa474340581d116936497abb","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":3,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":51,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"extraTitle":"","html":"<html><head></head><body><p>Good to know</p></body></html>","htmlText":"<html><head></head><body><p>Good to know</p></body></html>","text":"Good to know","highlighted":1,"essential":1,"paper":1,"likeSize":10,"commentSize":4,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/837908614","repostId":2162087249,"repostType":4,"repost":{"id":"2162087249","kind":"news","pubTimestamp":1629848100,"share":"https://ttm.financial/m/news/2162087249?lang=&edition=full","pubTime":"2021-08-25 07:35","market":"us","language":"en","title":"After-Hours Stock Movers : Limoneira,Urban Outfitters,Mimecast and more","url":"https://stock-news.laohu8.com/highlight/detail?id=2162087249","media":"StreetInsider","summary":"After-Hours Stock Movers:\nFSD Pharma Inc.  11% LOWER; announced today that it intends to terminate t","content":"<p>After-Hours Stock Movers:</p>\n<p><a href=\"https://laohu8.com/S/HUGE\">FSD Pharma Inc</a>. &nbsp;11% LOWER; announced today that it intends to terminate the Phase 2 clinical trial of ultra-micronized palmitoylethanolamide (\"PEA\"), or FSD-201, for use in treating COVID-19.</p>\n<p><a href=\"https://laohu8.com/S/BLFS\">BioLife Solutions Inc.</a>&nbsp;10.56% HIGHER; will replace Saia in the S&amp;P SmallCap 600</p>\n<p><a href=\"https://laohu8.com/S/LMNR\">Limoneira</a>&nbsp;10.7% LOWER; Prelim. Q3 Guidance Misses Consensus</p>\n<p><a href=\"https://laohu8.com/S/MIME\">Mimecast</a> 7.12% HIGHER; will replace Cinemark Holdings Inc. (NYSE: CNK) in the S&amp;P MidCap 400</p>\n<p><a href=\"https://laohu8.com/S/OPCH\">Option Care Health Inc</a>.&nbsp; 8% HIGHER; will replace Trustmark Corp. (NASDAQ: TRMK) in the S&amp;P MidCap 400</p>\n<p><a href=\"https://laohu8.com/S/JWN\">Nordstrom</a> 7.7% LOWER; reported Q2 EPS of $0.49, $0.21 better than the analyst estimate of $0.28. Revenue for the quarter came in at $3.66 billion versus the consensus estimate of $3.31 million. Revenue growth, including retail sales and credit card revenues of more than 35 percent.</p>\n<p><a href=\"https://laohu8.com/S/URBN\">Urban Outfitters</a> (NASDAQ: URBN) 5.2% LOWER; reported Q2 EPS of $1.28, $0.50 better than the analyst estimate of $0.78. Revenue for the quarter came in at $1.16 billion versus the consensus estimate of $1.08 billion.</p>\n<p><a href=\"https://laohu8.com/S/INTU\">Intuit</a> 1.8% HIGHER; reported Q4 EPS of $1.97, $0.29 better than the analyst estimate of $1.68. Revenue for the quarter came in at $2.6 billion versus the consensus estimate of $2.32 billion. Intuit sees FY2022 EPS of $11.05-$11.25, versus the consensus of $10.83. Intuit sees FY2022 revenue of $11.05-11.2 billion, versus the consensus of $10.94 billion. Intuit sees Q1 2022 EPS of $0.94-$0.99, versus the consensus of $1.14.</p>\n<p><a href=\"https://laohu8.com/S/TECH\">Bio-Techne</a> 1% HIGHER; will replace Maxim Integrated Products Inc. (NASDAQ: MXIM) in the S&amp;P 500</p>","source":"highlight_streetinsider","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>After-Hours Stock Movers : Limoneira,Urban Outfitters,Mimecast and more</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAfter-Hours Stock Movers : Limoneira,Urban Outfitters,Mimecast and more\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-25 07:35 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.streetinsider.com/dr/news.php?id=18859138><strong>StreetInsider</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>After-Hours Stock Movers:\nFSD Pharma Inc.  11% LOWER; announced today that it intends to terminate the Phase 2 clinical trial of ultra-micronized palmitoylethanolamide (\"PEA\"), or FSD-201, for use in ...</p>\n\n<a href=\"https://www.streetinsider.com/dr/news.php?id=18859138\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://www.streetinsider.com/dr/news.php?id=18859138","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2162087249","content_text":"After-Hours Stock Movers:\nFSD Pharma Inc.  11% LOWER; announced today that it intends to terminate the Phase 2 clinical trial of ultra-micronized palmitoylethanolamide (\"PEA\"), or FSD-201, for use in treating COVID-19.\nBioLife Solutions Inc. 10.56% HIGHER; will replace Saia in the S&P SmallCap 600\nLimoneira 10.7% LOWER; Prelim. Q3 Guidance Misses Consensus\nMimecast 7.12% HIGHER; will replace Cinemark Holdings Inc. (NYSE: CNK) in the S&P MidCap 400\nOption Care Health Inc.  8% HIGHER; will replace Trustmark Corp. (NASDAQ: TRMK) in the S&P MidCap 400\nNordstrom 7.7% LOWER; reported Q2 EPS of $0.49, $0.21 better than the analyst estimate of $0.28. Revenue for the quarter came in at $3.66 billion versus the consensus estimate of $3.31 million. Revenue growth, including retail sales and credit card revenues of more than 35 percent.\nUrban Outfitters (NASDAQ: URBN) 5.2% LOWER; reported Q2 EPS of $1.28, $0.50 better than the analyst estimate of $0.78. Revenue for the quarter came in at $1.16 billion versus the consensus estimate of $1.08 billion.\nIntuit 1.8% HIGHER; reported Q4 EPS of $1.97, $0.29 better than the analyst estimate of $1.68. Revenue for the quarter came in at $2.6 billion versus the consensus estimate of $2.32 billion. Intuit sees FY2022 EPS of $11.05-$11.25, versus the consensus of $10.83. Intuit sees FY2022 revenue of $11.05-11.2 billion, versus the consensus of $10.94 billion. Intuit sees Q1 2022 EPS of $0.94-$0.99, versus the consensus of $1.14.\nBio-Techne 1% HIGHER; will replace Maxim Integrated Products Inc. (NASDAQ: MXIM) in the S&P 500","news_type":1,"symbols_score_info":{"BLFS":0.9,"HUGE":0.9,"JWN":0.9,"LMNR":0.9,"MIME":0.9,"OPCH":0.9}},"isVote":1,"tweetType":1,"viewCount":256,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":[],"verified":2,"subType":0,"readableState":1,"langContent":"EN","currentLanguage":"EN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":10,"xxTargetLangEnum":"ORIG"},"commentList":[],"isCommentEnd":true,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/837908614"}